Verzenio 50 mg

VERZENIO 50 MG tablets contain abemaciclib, a medication used to treat certain types of cancer. This oral tablet is manufactured by Eli Lilly Canada Inc. and is available in a 50 MG strength.

VERZENIO 50 MG tablets are typically used in the treatment of advanced or metastatic breast cancer. Abemaciclib is often prescribed in combination with other therapies to help manage cancer growth. Patients may wonder, 'What is VERZENIO used for?' This medication is specifically designed to target and inhibit cancer cell proliferation.

Common effects of VERZENIO 50 MG tablets may include fatigue, nausea, and diarrhea. Some users might experience a decrease in appetite or hair loss. It's important to note that individual responses to abemaciclib can vary, and not everyone will experience these effects.

VERZENIO 50 MG tablets should be handled with care and stored as directed. Patients should follow their healthcare provider's instructions for administration. It's crucial to inform your healthcare provider about any pre-existing conditions or allergies before starting this medication.

VERZENIO 50 MG tablets may interact with certain medications, including those that are metabolized by the liver. Alcohol and other substances that affect liver enzymes could potentially alter the effectiveness of abemaciclib. Always consult with a healthcare provider before combining VERZENIO with other treatments.